Risks vs Benefits for SGLT2 Inhibitor Medications.
Year: 2018
Type: article
Abstract: Health care providers should carefully assess patients with diabetes mellitus before prescribing sodium-glucose cotransporter 2 inhibitor medications and monitor for adverse effects.
Source: Europe PMC (PubMed Central)
Institutions: Mercy St. Vincent Medical Center, University of Louisville
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2981923332
